The study characterizes the lung cancer tumor microenvironment, linking cellular compositions to immunotherapy resistance and ...

Hopes of a bright new future in stroke risk management in AF were dashed when asundexian failed against apixaban in the ...

A recent study reveals that microplastics in human blood may disrupt clotting processes, raising the risk of heart diseases.

Sirius Therapeutics today announced that preliminary data from its Phase 1 clinical trial of SRSD107, a next generation siRNA ...

For people with the bleeding disorder hemophilia, life can seem like one continuous state of alertness. If they accidentally ...

Whether you should be on heart attack medication depends on your medical history, such as having high blood pressure. Find a ...

This study aims to evaluate the regulatory role of the novel adenosine monophosphate-activated protein kinase (AMPK) agonist O304 in AAA formation and explore its underlying molecular ... We developed ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved HYMPAVZI™ (marstacimab-hncq) for routine ...

The initial formation of the RH is critical — it provides a scaffold where cells can gather ... They form a 3D network that incorporates essential proteins, platelets, and growth factors from the ...

The reality show premieres today (November 17) at 9pm on ITV with a 105-minute special opening episode and the season will continue all the way through to December 8. Reflecting on her upcoming ...